NASDAQ:MIRO
Miromatrix Medical Inc.
- Stock
Last Close
3.37
12/12 21:00
Market Cap
92.95M
Beta: -
Volume Today
631.56K
Avg: 57.52K
PE Ratio
−3.41
PFCF: −3.79
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
---|---|---|---|---|---|
average inventory | 400.05K - | 800.10K 100% | |||
average payables | 216.57K - | 1.11M 413.69% | 1.84M 65.38% | ||
average receivables | 321.50K - | 694.99K 116.17% | 1.16M 66.41% | ||
book value per share | -3.95 - | -4.83 22.12% | 4.71 197.61% | 1.26 73.27% | |
capex per share | -0.01 - | -0.01 20.37% | -0.29 2,428.03% | -0.05 82.59% | |
capex to depreciation | -0.29 - | -0.72 145.23% | -20.15 2,687.00% | -0.96 95.24% | |
capex to operating cash flow | 0.01 - | 0.02 25.74% | 0.23 1,390.83% | 0.04 82.56% | |
capex to revenue | -0.41 - | -2.65 552.28% | -102.31 3,765.25% | -1.12 98.91% | |
cash per share | 0.31 - | 0.42 35.58% | 4.60 993.63% | 1.22 73.56% | |
days of inventory on hand | 584.07 - | 584.07 0% | |||
days payables outstanding | 442.36 - | 95.02 78.52% | 1.53K 1,509.45% | 1.16K 24.34% | |
days sales outstanding | 770.60 - | 903.69 17.27% | 14.07K 1,457.12% | 397.44 97.18% | |
debt to assets | 0.15 - | 1.40 851.24% | 0.01 99.02% | 0.10 649.54% | |
debt to equity | -0.03 - | -0.14 423.89% | 0.02 110.67% | 0.14 786.60% | |
dividend yield | |||||
earnings yield | -0.02 - | -0.05 181.48% | -0.28 413.15% | -0.48 74.38% | |
enterprise value | 157.60M - | 163.98M 4.05% | 1.88M 98.85% | 60.32M 3,105.34% | |
enterprise value over ebitda | -17.25 - | -14.33 16.96% | -0.11 99.22% | -2.02 1,698.99% | |
ev to operating cash flow | -18.93 - | -20.40 7.77% | -0.13 99.38% | -2.26 1,679.01% | |
ev to sales | 630.39 - | 3.52K 459.06% | 56.91 98.39% | 63.26 11.16% | |
free cash flow per share | -0.80 - | -0.77 3.98% | -1.58 105.17% | -1.34 15.50% | |
free cash flow yield | -0.05 - | -0.05 3.98% | -0.34 566.68% | -0.45 32.55% | |
graham net net | -4.34 - | -4.90 12.70% | 4.12 184.22% | 0.85 79.27% | |
graham number | 5.11 - | 9.46 85.40% | 11.75 24.15% | 6.41 45.49% | |
income quality | 2.06 - | 0.78 62.10% | 1.01 29.47% | 0.89 11.77% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | |
interest coverage | -185.84 - | -13.41 92.79% | -25.07 86.98% | -633.66 2,427.68% | |
interest debt per share | 0.11 - | 0.77 577.63% | 0.13 82.89% | 0.17 32.34% | |
inventory turnover | 0.62 - | 0.62 0% | |||
invested capital | -0.03 - | -0.14 423.89% | 0.02 110.67% | 0.14 786.60% | |
market cap | 159.71M - | 161.09M 0.86% | 53.86M 66.56% | 61.98M 15.06% | |
net current asset value | -45.31M - | -51.60M 13.89% | 48.53M 194.06% | 18.66M 61.56% | |
net debt to ebitda | 0.23 - | -0.25 209.50% | 3.10 1,322.90% | 0.06 98.21% | |
net income per share | -0.29 - | -0.82 181.48% | -1.30 57.92% | -1.45 11.17% | |
operating cash flow per share | -0.79 - | -0.76 4.27% | -1.29 69.57% | -1.29 0.17% | |
payables turnover | 0.83 - | 3.84 365.55% | 0.24 93.79% | 0.32 32.17% | |
receivables turnover | 0.47 - | 0.40 14.73% | 0.03 93.58% | 0.92 3,440.54% | |
research and ddevelopement to revenue | 25.07 - | 156.48 524.24% | 325.12 107.78% | 19.20 94.10% | |
return on tangible assets | -0.40 - | -1.66 318.52% | -0.25 85.20% | -0.86 251.67% | |
revenue per share | 0.02 - | 0.00 81.55% | 0.00 34.60% | 0.05 1,497.66% | |
roe | 0.07 - | 0.17 130.49% | -0.28 261.78% | -1.15 315.98% | |
roic | 0.07 - | 0.20 176.04% | -0.31 258.48% | -0.92 193.35% | |
sales general and administrative to revenue | 9.74 - | 45.33 365.21% | 140.43 209.80% | 9.15 93.49% | |
shareholders equity per share | -3.95 - | -4.83 22.12% | 4.71 197.61% | 1.26 73.27% | |
stock based compensation to revenue | 3.67 - | 13.86 277.22% | 18.82 35.77% | 1.21 93.58% | |
tangible asset value | -41.43M - | -51.03M 23.17% | 54.13M 206.06% | 26.11M 51.77% | |
tangible book value per share | -3.95 - | -4.83 22.12% | 4.71 197.61% | 1.26 73.27% | |
working capital | 2.25M - | -3.47M 254.44% | 50.77M 1,561.40% | 22.36M 55.95% |
All numbers in USD (except ratios and percentages)